During the acute phase of allergy (effector phase), IgE molecules on mast cells and basophils crosslink the cells’ high affinity IgE receptors, initiating a signaling cascade that leads to the release of preformed mediators, enzymes and cytokines, resulting in pathological damage and clinical manifestation of allergy [17–19]. This evidence concerns the gene IGHE and allergic disease.